BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20080251)

  • 1. Intrasplenic preconditioning: a model for the study of xenostimuli accommodation.
    Telpner R; Ben-Abraham R; Klein Y; Nakache R; Khoury W; Weinbroum AA
    J Surg Res; 2011 Jun; 168(1):135-42. PubMed ID: 20080251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intervention strategies and agents mediating the prevention of xenorejection.
    Ghebremariam YT; Smith SA; Anderson JB; Kahn D; Kotwal GJ
    Ann N Y Acad Sci; 2005 Nov; 1056():123-43. PubMed ID: 16387682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenotransplantation of discordant, immediately-vascularized organs.
    Bach FH
    Clin Transplant; 1993 Feb; 7(1 part 2):90-2. PubMed ID: 10148368
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoglobulin G profile in hyperacute rejection after multivisceral xenotransplantation.
    Galvao FH; Soler W; Pompeu E; Waisberg DR; Mello ES; Costa AC; Teodoro W; Velosa AP; Capelozzi VL; Antonangelo L; Catanozi S; Martins A; Malbouisson LM; Cruz RJ; Figueira ER; Filho JA; Chaib E; D'Albuquerque LA
    Xenotransplantation; 2012; 19(5):298-304. PubMed ID: 22957972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunobiology of discordant xenograft rejection and potential therapeutic modalities.
    Robson SC; Candinas D; Winkler H; Kopp C; Hancock WW; Bach FH
    Transplant Proc; 1996 Jun; 28(3):1154-5. PubMed ID: 8658607
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of species-specific host accommodation in the hamster-to-rat xenotransplantation model.
    Yin D; Ma LL; Blinder L; Shen J; Sankary H; Williams JW; Chong AS
    J Immunol; 1998 Aug; 161(4):2044-51. PubMed ID: 9712078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic engineering as an approach to xenotransplantation.
    Bach FH
    World J Surg; 1997; 21(9):913-6. PubMed ID: 9361504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human xenoreactive natural antibodies--avidity and targets on porcine endothelial cells.
    Vanhove B; Bach FH
    Transplantation; 1993 Nov; 56(5):1251-3. PubMed ID: 8249132
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac xenografting in the pig-to-rhesus monkey model: manipulation of antiendothelial antibody prolongs survival.
    Fischel RJ; Matas AJ; Platt JL; Perry E; Noreen H; Shumway SJ; Bolman RM
    J Heart Lung Transplant; 1992; 11(5):965-73; discussion 973-4. PubMed ID: 1420246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo IgM depletion by anti-mu monoclonal antibody therapy. The role of IgM in hyperacute vascular rejection of discordant xenografts.
    Soares M; Lu X; Havaux X; Baranski A; Reding R; Latinne D; Daha M; Lambotte L; Bach FH; Bazin H
    Transplantation; 1994 Apr; 57(7):1003-9. PubMed ID: 8165695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural antipig xenoantibody is absent in neonatal human serum.
    Xu H; Edwards NM; Chen JM; Dong X; Michler RE
    J Heart Lung Transplant; 1995; 14(4):749-54. PubMed ID: 7578185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperacute rejection of hDAF-transgenic pig organ xenografts in cynomolgus monkeys: influence of pre-existing anti-pig antibodies and prevention by the alpha GAL glycoconjugate GAS914.
    Lam TT; Hausen B; Boeke-Purkis K; Paniagua R; Lau M; Hook L; Berry G; Higgins J; Duthaler RO; Katopodis AG; Robbins R; Reitz B; Borie D; Schuurman HJ; Morris RE
    Xenotransplantation; 2004 Nov; 11(6):517-24. PubMed ID: 15479461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FK778 in experimental xenotransplantation: a detailed analysis of drug efficacy.
    Schrepfer S; Deuse T; Koch-Nolte F; Krieger T; Haddad M; Schäfer H; Pelletier MP; Robbins RC; Reichenspurner H
    J Heart Lung Transplant; 2007 Jan; 26(1):70-7. PubMed ID: 17234520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Natural human anti-pig agglutinins. Role in the hyperacute rejection of xenogeneic graft in the pig-human donor-recipient combination].
    Gautreau C; Cardoso J; Houssin D
    Chirurgie; 1994-1995; 120(9):503-6. PubMed ID: 7641556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic engineering of endothelial cells to ameliorate xenograft rejection.
    Bach FH; Robson SC; Wrighton CJ; Stuhlmeier K; Ferran C; Winkler H
    Clin Transplant; 1996 Feb; 10(1 Pt 2):124-7. PubMed ID: 8680048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathology of xenografts in pig to non-human primate discordant xenotransplantation.
    Shimizu A; Yamada K
    Clin Transplant; 2010 Jul; 24 Suppl 22():11-5. PubMed ID: 20590687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xenograft rejection: IgG1, complement and NK cells team up to activate and destroy the endothelium.
    Rieben R; Seebach JD
    Trends Immunol; 2005 Jan; 26(1):2-5. PubMed ID: 15629401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of xenotransplant rejection].
    Candinas D; Seebach JD
    Zentralbl Chir; 1999; 124(7):591-9. PubMed ID: 10474871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A primate model for discordant pig to primate kidney xenotransplantation without hyperacute graft rejection.
    Loss M; Schmidtko J; Przemeck M; Kunz R; Arends H; Jalali A; Lorenz R; Piepenbrock S; Klempnauer J; Winkler M
    J Invest Surg; 2001; 14(1):21-9. PubMed ID: 11297057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Xenotransplantation: physiopathology of hyperacute and differentiated rejection, and therapeutic perspectives].
    Malassagne B; Calmus Y; Houssin D; Weill B
    Pathol Biol (Paris); 2000 May; 48(4):377-82. PubMed ID: 10868402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.